Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Lung
Published in: Lung 6/2015

01-12-2015

Lung and Chest-Wall Metastasis of Liposarcoma

Authors: Miriam Menna Barreto, Helena Ribeiro Fortes, Paulo Marcos Valiante, Gláucia Zanetti, Edson Marchiori

Published in: Lung | Issue 6/2015

Login to get access

Excerpt

A 57-year-old woman was admitted to our institution with a painful mass on the right thigh. Biopsy revealed dedifferentiated liposarcoma (LS). The lesion was surgically resected, and the patient underwent 4 months of radiotherapy. 1 year later, she developed a growing mass in the posterior chest wall associated with pain and paraplegia. The mass was fixed to the left paraspinal region and measured approximately 8 cm. …
Literature
1.
Tirumani SH, Tirumani H, Jagannathan JP et al (2015) Metastasis in dedifferentiated liposarcoma: predictors and outcome in 148 patients. Eur J Surg Oncol 41(7):899–904CrossRefPubMed
2.
Bicakcioglu P, Sak SD, Tastepe AI (2012) Liposarcoma of the chest wall. Transformation of dedifferentiated liposarcoma from a recurrent lipoma. Saudi Med J 33(8):901–903PubMed
3.
Murphey MD, Arcara LK, Fanburg-Smith J (2005) From the archives of the AFIP: imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation. Radiographics 25(5):1371–1395CrossRefPubMed
4.
Foran P, Colleran G, Madewell J et al (2011) Imaging of thoracic sarcomas of the chest wall, pleura, and lung. Semin Ultrasound CT MR 32(5):365–376CrossRefPubMed
Metadata
Title
Lung and Chest-Wall Metastasis of Liposarcoma
Authors
Miriam Menna Barreto
Helena Ribeiro Fortes
Paulo Marcos Valiante
Gláucia Zanetti
Edson Marchiori
Publication date
01-12-2015
Publisher
Springer US
Published in
Lung / Issue 6/2015
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-015-9779-6

Other articles of this Issue 6/2015

Lung 6/2015 Go to the issue

OriginalPaper

Which is the Role of Pneumonectomy in the Era of Parenchymal-Sparing Procedures? Early/Long-Term Survival and Functional Results of a Single-Center Experience

ReviewPaper

Vitamin D Status in South Africa and Tuberculosis

OriginalPaper

Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study

OriginalPaper

MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH

OriginalPaper

Effects of Vascular Endothelial Growth Factor in Recovery Phase of Acute Lung Injury in Mice

OriginalPaper

Effects of Twenty Days of the Ketogenic Diet on Metabolic and Respiratory Parameters in Healthy Subjects
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits